Exam Details
Subject | clinical research | |
Paper | ||
Exam / Course | pharm d (6–ydc) | |
Department | ||
Organization | G. Pulla Reddy College Of Pharmacy | |
Position | ||
Exam Date | July, 2017 | |
City, State | telangana, hyderabad |
Question Paper
FACULTY OF PHARMACY
Pharm. D YDC) V-Year (Main) Examination, July 2017
Subject Clinical Research
Time 3 Hours Max. Marks: 70
Note: Answer all questions from Part A and answer any five questions from Part-B.
PART A (10 x 2 20 Marks)
1 Mention different types of preclinical studies.
2 What are the requirements to conduct clinical trials as per schedule
3 What is ANDA? How is it filed
4 Explain briefly the steps involved in CDM.
5 What is PIC? Explain its role.
6 What is ICMR code?
7 Define the terms "protocol" and "protocol amendments".
8 What is a regulatory authority? Write the general roles and responsibilities of regular
authority.
9 What is "subject identification code" in clinical trials?
10 Write the composition of IRB and explain quorum for meetings.
PART B x 10 50 Marks)
11 Explain Dosage form development process.
12 Explain the principles of CDSCO GCP guidelines.
Explain the roles and responsibilities of Auditors as per ICH GCP.
13 What are the contents of INDA How IND application is reviewed?
14 Who is a sponsor? Enumerate sponsor's responsibilities as per ICH GCP.
15 Explain randomization in clinical trials.
Write notes on multicentre trials.
16 Discuss various toxicological testing required for discovery of new drugs.
17 Explain various Data Entry methods.
Write about safety monitoring in clinical Trials.
18 Explain in detail responsibilities of investigator as per ICH GCP.
Give an overview of Regulatory Environment in Europe.
Pharm. D YDC) V-Year (Main) Examination, July 2017
Subject Clinical Research
Time 3 Hours Max. Marks: 70
Note: Answer all questions from Part A and answer any five questions from Part-B.
PART A (10 x 2 20 Marks)
1 Mention different types of preclinical studies.
2 What are the requirements to conduct clinical trials as per schedule
3 What is ANDA? How is it filed
4 Explain briefly the steps involved in CDM.
5 What is PIC? Explain its role.
6 What is ICMR code?
7 Define the terms "protocol" and "protocol amendments".
8 What is a regulatory authority? Write the general roles and responsibilities of regular
authority.
9 What is "subject identification code" in clinical trials?
10 Write the composition of IRB and explain quorum for meetings.
PART B x 10 50 Marks)
11 Explain Dosage form development process.
12 Explain the principles of CDSCO GCP guidelines.
Explain the roles and responsibilities of Auditors as per ICH GCP.
13 What are the contents of INDA How IND application is reviewed?
14 Who is a sponsor? Enumerate sponsor's responsibilities as per ICH GCP.
15 Explain randomization in clinical trials.
Write notes on multicentre trials.
16 Discuss various toxicological testing required for discovery of new drugs.
17 Explain various Data Entry methods.
Write about safety monitoring in clinical Trials.
18 Explain in detail responsibilities of investigator as per ICH GCP.
Give an overview of Regulatory Environment in Europe.
Other Question Papers
Subjects
- biology
- biopharmaceutics & pharmacokinetics
- biostatistics & research methodology
- clinical & pharmacokinetics pharmacotherapeutic drug monitoring
- clinical pharmacokinetics and pharmacotherapeutic drug monitoring
- clinical pharmacy
- clinical research
- clinical toxicology
- community pharmacy
- hospital pharmacy
- human anatomy and physiology
- medicinal biochemistry
- medicinal chemistry
- pathophysiology
- pharmaceutical analysis
- pharmaceutical formulations
- pharmaceutical inorganic chemistry
- pharmaceutical jurisprudence
- pharmaceutical microbiology
- pharmaceutical organic chemistry
- pharmaceutics
- pharmacoepidmiology and pharmacoeconomics
- pharmacognosy & phytopharmaceuticals
- pharmacology – i
- pharmacology – ii
- pharmacotherapeutics – i
- pharmacotherapeutics – iii
- pharmacotherapeutics-ii